BRCA2 and melanoma: Tuominen et al. also found an association with a founder mutation in a case control study of BRCA2 in Swedish melanoma patients with an odds ratio of 2.80 (95% CI: 1.04–7.58, p = 0.035).[25] Debniak et al. did not find and excess of BRCA1 or BRCA2 mutations in a sample of melanoma patients from Poland [26].